Results 31 to 40 of about 5,741,783 (179)

Single‐Cell Analysis Clarifies Pathological Heterogeneity in Tenosynovial Giant Cell Tumor and Identifies Biomarkers for Predicting Disease Recurrence [PDF]

Advanced Science
Diffuse‐type tenosynovial giant cell tumor (D‐TGCT) and localized‐type tenosynovial giant cell tumor (L‐TGCT) share common genomic aberrations and histopathological features, but the former has a more aggressive nature and a higher recurrence rate ...
Yubin Xie, Chen Chen, Fei Wu, Yiman Peng, Jing Su, Yang Zhao, Hongjie Huang, Zhong Alan Li, Yin Pei, Wencui Li, Yi He, Tianchen Xue, Chenxi Cao, Sui Peng, Xin Zhang, Weidong Song   +15 more
doaj   +2 more sources

Differential diagnosis of gout and tenosynovial giant cell tumor, a case report [PDF]

Современная ревматология
Gout is the most common inflammatory joint disease, related to microcrystalline arthritis. With improper or inadequate treatment, gout can lead to disability.A patient with a misdiagnosis of tophaceous gout is described in whom a differential diagnosis ...
P. I. Pyatnitskaya, E. N. Otteva, E. V. Polukhina   +2 more
doaj   +2 more sources

Treatment Modalities for Refractory-Recurrent Tenosynovial Giant Cell Tumor (TGCT): An Update [PDF]

Medicina
Background and Objectives: Tenosynovial giant cell tumor (TGCT) is a rare, locally aggressive, benign neoplasm arising from the synovium of joints, tendon sheaths, and bursa.
Vasiliki Dania, Nikolaos A. Stavropoulos, Panayiotis Gavriil, Ioannis Trikoupis, Panagiotis Koulouvaris, Olga D. Savvidou, Andreas F. Mavrogenis, Panayiotis J. Papagelopoulos   +7 more
doaj   +2 more sources

Intramuscular Tenosynovial Giant Cell Tumor, Diffuse-Type [PDF]

Journal of Pathology and Translational Medicine, 2016
Tenosynovial giant cell tumors (TSGCT), a group of tumors that originate in tendon sheaths, joints, bursae, or adjacent soft tissue, were first described in 1941 by Jaffe et al. [1]. Diffuse-type TSGCT are known to be located in the periarticular soft tissue, while pure intramuscular tumors are rare.
Yoo Jin Lee, Youngjin Kang, Jiyoon Jung, Seojin Kim, Chul Hwan Kim   +4 more
doaj   +3 more sources

Localized tenosynovial giant cell tumor in the posterior compartment of the knee - A rare case report

Journal of Orthopaedic Reports, 2023
Background and purpose: Localized tenosynovial giant cell tumors represent a rare benign proliferative disorder of the synovial and surrounding tissue. This condition has insidious and unspecific symptoms that make its diagnosis challenging.
Luís Alves, Maria João Leite, Sara Lima, Tiago Torres, Manuel Gutierres   +4 more
doaj   +1 more source

Tenosynovial Giant Cell Tumor [PDF]

, 2020
Tenosynovial giant cell tumors actually are a family of neoplasms most often arising from the synovium of joints, bursae, and tendon sheaths.
openaire   +4 more sources

Peroneal tenosynovial giant cell tumor in the sinus tarsi: A rare case report

Foot & Ankle Surgery: Techniques, Reports & Cases, 2021
Tenosynovial giant cell tumor (TSGCT) is a benign, solitary soft-tissue mass which is derived from synovial cells of the tendon sheath. Foot and ankle related lesions are less commonly observed as compared to the upper extremity related lesions.
Hakan Zeybek, MD
doaj   +1 more source

Tenosynovial Giant Cell Tumor in the Gruberi Bursa [PDF]

Balkan Medical Journal
Fábio Ferreira, Diana Baptista, Miguel Castro   +2 more
doaj   +2 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor

Drugs in R&D, 2020
Tenosynovial giant cell tumor is a rare proliferative tumor that arises from the synovium, bursae, or tendon sheaths due to an overproduction of colony-stimulating factor 1.
Shanada Monestime, Dovena Lazaridis
doaj   +1 more source